These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4619051)

  • 1. [History of the arsenicals with a melaminyl radical. Remarks on a study by Janssens].
    Friedheim E
    Bull Soc Pathol Exot Filiales; 1974; 67(4):400-2. PubMed ID: 4619051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human african trypanosomiasis: A history of its therapies and their failures].
    Ollivier G; Legros D
    Trop Med Int Health; 2001 Nov; 6(11):855-63. PubMed ID: 11703839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.
    Veeken HJ; Ebeling MC; Dolmans WM
    Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of human African trypanosomiasis].
    Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
    Jennings FW
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EEG and treatment with Arsobal in human African trypanosomiasis].
    Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic arsenic-induced Guillain-Barré-like syndrome due to melarsoprol: a clinical, electrophysiological, and pathological study.
    Gherardi RK; Chariot P; Vanderstigel M; Malapert D; Verroust J; Astier A; Brun-Buisson C; Schaeffer A
    Muscle Nerve; 1990 Jul; 13(7):637-45. PubMed ID: 2167451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement: a sign of infestation of sheep by Trypanosoma brucei brucei in an experimental model: its evolution following treatment].
    Bouteille B; Darde ML; Monteil J; Pestre-Alexandre M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):522-31. PubMed ID: 3197249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [African trypanosomiasis at the Claude-Bernard Hospital (diagnostic circumstances and therapeutic problems)].
    Coulaud JP; Vachon F; Lebigot P; Lagarde P; Pasticier A; Saimot G
    Ann Med Interne (Paris); 1975; 126(8-9):671-6. PubMed ID: 1217776
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaloids to arsenicals: systematic drug discovery before the first world war.
    Parascandola J
    Publ Am Inst Hist Pharm; 1997; 16():77-91. PubMed ID: 11619902
    [No Abstract]   [Full Text] [Related]  

  • 18. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Products with a melaminyl radical in the treatment of human trypanosomiasis gambiense].
    JONCHERE H; GOMER J; REYNAUD R
    Bull Soc Pathol Exot Filiales; 1953; 46(3):386-96. PubMed ID: 13094465
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.